Isotype: Fusion - FLT1 (fms-related tyrosine kinase 1, vascular endothelial growth factor receptor 1, VEGFR-1, VEGFR, FLT, FRT, vascular permeability factor receptor) domain 2 fragment (14-204) - KDR (kinase insert domain receptor, vascular endothelial growth factor receptor 2, VEGFR2, VEGF-R2, FLK1, CD309) domain 3 fragment (206-308) - IGHG1 Fc (Fragment constant (205-431)) - CR1 (complement receptor type 1, C3b/C4b receptor, C3BR, Knops blood group, KN, CD35) fragment (1-192)
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Accession: P01024 & P0C0L5 & P15692
Host species: Human
Isotype: Fusion - [FLT1 (fms-related tyrosine kinase 1, vascular endothelial growth factor receptor 1, VEGFR-1, VEGFR, FLT, FRT, vascular permeability factor receptor) domain 2 fragment (132-232) - KDR (kinase insert domain receptor, vascular endothelial growth factor receptor 2, VEGFR2, VEGF-R2, FLK1, CD309) domain 3 fragment (227-327) - FGFR1 (fibroblast growth factor receptor 1, FLT2, KAL2) domains 2 and 3 fragment (150-361)]2 - IGHG1 Fc (Fragment constant)
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Applications: Used for the quantitative determination of Bevacizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 98.1 ng/mL
Range: 312.5 - 20,000 ng/mL
Host species: Human
Isotype: immunoglobulin Fab G1-kappa
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q6UXB2
Protein length: Leu24-Leu119
Applications: Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Expression system: Mammalian Cells
Accession: Q00731
Protein length: Ala27-Leu190
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, WB
Accession: P15692
Host species: Mouse
Isotype: IgG1
Applications: ELISA, IF, WB
Accession: P15692
